22
Participants
Start Date
June 30, 2011
Primary Completion Date
June 30, 2012
Study Completion Date
January 31, 2013
PDM08
To assess the tolerability and safety of increasing multiple doses administration of PDM08: 560 μg, 1.12, 2.24, 3.5, 14, 28 and 56 mg administered twice a week for four weeks in patients with advanced solid tumours for which there is no standard therapy or they are refractory to it.
Hospital Universitario La Paz, Madrid
Prodimed S.A.
OTHER